J. Kevin Buchi - 12 Mar 2025 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Reporting relationship: Director
Issuer ticker: BNTC
Reported as of: 12 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Mar 2025, 16:43:09 UTC
Prior SEC filing: 12 Mar 2025
Next SEC filing: 08 May 2025
Source filing: View source filing
Reporting owner signature: /s/ J. Kevin Buchi

Key filing fact

J. Kevin Buchi filed Form 4 for Benitec Biopharma Inc. (BNTC) on 13 Mar 2025.

Key facts

This page summarizes J. Kevin Buchi's Form 4 filing for Benitec Biopharma Inc. (BNTC).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Mar 2025, 16:43.

Change

Previous filing in this sequence was filed on 12 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BNTC transaction

Common Stock

Gift

Transaction value: $0
Shares: -103,626
Change %: -100%
Price: $0.000000
Shares after: 284
Date: 12 Mar 2025
Ownership: Direct

BNTC transaction

Common Stock

Gift

Transaction value: $0
Shares: +103,626
Change %
Price: $0.000000
Shares after: 103,626
Date: 12 Mar 2025
Ownership: By Trust
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On March 12, 2025, the reporting person gifted 103,626 shares of Common Stock to a trust for no consideration. The reporting person is trustee of the trust and the reporting person's son is the sole beneficiary.